Author: davron.bowman

As we enter December 2025, multiple respiratory viruses are surfacing simultaneously. Diagnostic labs, children’s hospitals and public health agencies are warning that cases are climbing in schools

Discover influenza’s turbulent history (including some controversial chapters), current trends and worries on experts’ radar, and the hopeful strides in detection and treatment that could redefine our fight against the flu.

This past week, the BioPathogenix team joined in the local Trunk or Treat celebration in Central Kentucky, and it was all smiles, costumes, and candy! 

Led by Scientist-turned-digital-marketer, Yue Yu, the qPCR & Pathogen Detection Circle brings together scientific professionals across academia, industry, and public health to create an open forum for knowledge exchange and technical refinement.

This guide helps researchers identify and correct the most common PCR and qPCR issues experienced in diagnostic and research laboratories.

Each year, seasonal influenza resurfaces in force, bringing waves of illness that strain public health systems and laboratories alike. In the United States, flu season usually begins in the fall and peaks during the winter months – most often between December and February.

The ebb and flow of seasonal respiratory pathogens – notably influenza and respiratory syncytial virus (RSV) – pose a perennial challenge to public health and diagnostic laboratories.

We celebrate three trailblazing researchers of color whose names may not be household staples, but whose work shaped the molecular and biomedical advances we all depend on today.

Measles is staging an alarming comeback in the United States, a country that declared the disease eliminated in 2000. By June 2025, the U.S. had recorded 1,197 measles cases across 35 states – already more than four times the total in all of 2024.

Measles, once declared eliminated domestically in 2000, has resurged with nearly 900 confirmed cases spanning 26 states